Tadalafil is not approved by any major regulatory body for treating premature ejaculation, and the most rigorous evidence to date suggests that taking it alone does not reliably delay ejaculation more than a placebo pill would. That said, the real-world picture is more complicated. When premature ejaculation occurs alongside erectile dysfunction, or when tadalafil is paired with another treatment, the drug appears to offer genuine benefits. Understanding which scenario applies to you determines whether tadalafil is worth discussing with your doctor.
What the Controlled Trials Show for Tadalafil Alone
The highest-quality evidence on tadalafil as a standalone PE treatment is not encouraging. A 2025 systematic review and meta-analysis pooling data from randomized controlled trials found no statistically significant difference in ejaculatory latency time between men taking daily tadalafil and those on placebo.1American Journal of Men’s Health. The Efficacy and Safety of Daily Use of Tadalafil in Treatment of Premature Ejaculation: A Systematic Review and Meta-Analysis A single-blind, placebo-controlled trial specifically targeting lifelong PE reached the same conclusion: both the tadalafil and placebo groups saw small improvements in ejaculatory latency over three months, but the gap between them was not meaningful.2PubMed Central. Effect of a tadalafil 5-mg single daily dose on lifelong premature ejaculation: A single-blinded placebo-controlled study In that trial, placebo-group participants actually improved nearly as much as tadalafil-group participants at the one-month mark, suggesting expectation and behavioral changes account for most of the observed benefit.
A broader meta-analysis looking at all classes of PE drugs, including PDE5 inhibitors like tadalafil, did find that PDE5 inhibitors as a group performed better than placebo. But the authors flagged a serious caveat: the studies were so inconsistent with one another that the pooled result is unreliable.3PubMed. Current Pharmacological Management of Premature Ejaculation: A Systematic Review and Meta-analysis When researchers talk about “high heterogeneity,” they mean the studies produced wildly different effect sizes, which usually signals that something other than the drug itself is driving the variation, such as patient selection, study design, or whether participants also had erectile dysfunction.
The Erectile Dysfunction Connection
The clearest evidence for tadalafil’s effect on ejaculation timing comes from men who also have erectile problems. A study that separated participants into two groups, one with both ED and PE and one with PE alone, found dramatically different outcomes. Men with both conditions saw their ejaculatory latency roughly triple after three months of daily tadalafil, jumping from about 37 seconds to around 120 seconds. Men with PE but without ED showed no meaningful improvement.4PubMed Central. Short- and long-term follow-up results of daily 5-mg tadalafil as a treatment for erectile dysfunction and premature ejaculation
This makes intuitive sense. When a man struggles to get or maintain an erection, he may rush to climax before losing firmness, creating what clinicians call acquired or secondary PE. Fix the erection problem, and the urgency disappears. Tadalafil’s well-established ability to improve erection quality gives men more confidence and less performance anxiety, both of which contribute to better ejaculatory control. In an open-label study of men with co-existing ED, PE, and lower urinary tract symptoms, daily tadalafil increased average ejaculatory latency from about 2.2 minutes to 3.4 minutes alongside meaningful improvements in erectile function scores.5PubMed Central. Effect of tadalafil 5mg daily treatment on the ejaculatory times, lower urinary tract symptoms and erectile function in patients with erectile dysfunction
The British Society for Sexual Medicine’s 2024 position statement on PE supports this framing, noting the need for more research into the association between PE and ED and endorsing the early use of PDE5 inhibitors, either alone or in combination with other interventions, when both conditions are present.6PubMed Central. British Society for Sexual Medicine (BSSM) Position Statement on Premature Ejaculation
Why Tadalafil Might Affect Ejaculation at All
Tadalafil works by blocking an enzyme called PDE5, which breaks down a signaling molecule involved in smooth muscle relaxation. That is why it helps erections: it keeps the blood vessels in the penis relaxed and dilated. But PDE5 is not just in penile tissue. Researchers have found relatively high levels of it in the vas deferens, the muscular tube that contracts to propel semen during ejaculation.7Molecular Human Reproduction. Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens By blocking PDE5 there, tadalafil may dampen the forceful contractions that drive the emission phase of ejaculation. This is a plausible peripheral mechanism, though the fact that tadalafil alone does not beat placebo for most men with lifelong PE suggests that the peripheral effect, on its own, is not powerful enough to shift ejaculatory timing in a clinically meaningful way.
Ejaculation is governed by a wider network of chemical signals in the brain and spinal cord, including serotonin, dopamine, norepinephrine, and nitric oxide.8PubMed. Etiology of ejaculation and pathophysiology of premature ejaculation The drugs that work best for lifelong PE, the SSRIs, act centrally on serotonin signaling. Tadalafil’s nitric oxide pathway is just one thread in a much larger web, which may explain why it works better as a supporting player than as a solo act.9Sexual Medicine Reviews. Current and Emerging Treatments for Premature Ejaculation
Tadalafil Combined With SSRIs or Dapoxetine
The combination story is where tadalafil’s role in PE management gets more interesting. Several trials have tested what happens when you add tadalafil to an SSRI, and the results are consistently better than the SSRI alone. In one double-blind study, the combination of fluoxetine and tadalafil produced a significantly greater increase in ejaculatory latency than fluoxetine alone, tadalafil alone, or placebo.10PubMed. Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study A trial using paroxetine found a similar pattern: the combination group trended toward better ejaculatory latency and reported greater intercourse satisfaction compared to paroxetine alone, though the latency difference in that study did not quite reach statistical significance.11Nephro-Urology Monthly. Comparison Between Tadalafil Plus Paroxetine and Paroxetine Alone in the Treatment of Premature Ejaculation
A broader trial combining SSRIs with PDE5 inhibitors (including tadalafil) found that using both before intercourse provided substantially longer ejaculatory times than the SSRI alone over a sustained treatment period.12PubMed. Combination therapy with selective serotonin reuptake inhibitors and phosphodiesterase-5 inhibitors in the treatment of premature ejaculation
One of the most informative head-to-head comparisons pitted tadalafil alone against dapoxetine alone against the combination of both. After 12 weeks, men on tadalafil alone and men on dapoxetine alone achieved almost identical improvements in ejaculatory latency. But those on the combination did significantly better than either single drug, with both longer ejaculatory times and higher satisfaction scores.13PubMed Central. Prospective comparison of tadalafil 5 mg, dapoxetine 30 mg, and the combination of both in the treatment of premature ejaculation That tadalafil matched dapoxetine, a drug specifically designed and approved for PE in several countries, is noteworthy. It suggests tadalafil has a real, if modest, effect on ejaculation even apart from its role in correcting ED, but that the effect works best when combined with a drug targeting serotonin pathways.
One trade-off: combination therapy does increase the rate of side effects. Studies comparing combination regimens to single drugs report mildly higher rates of headache, flushing, and dizziness, though these generally remain tolerable.14Urology Journal. Comparison of Dapoxetine/Tadalafil and Paroxetine/Tadalafil Combination Therapies for the Treatment of the Premature Ejaculation: A Randomized Clinical Trial A controlled trial comparing tadalafil plus sertraline to sertraline alone confirmed the pattern of greater efficacy alongside more frequent drug-related adverse events in the combination group.15Journal of Research in Urology. Efficacy and Safety of Combination Therapy with Tadalafil and Sertraline for Premature Ejaculation: A Double-blind Randomized Controlled Trial
Tadalafil With Topical Numbing Sprays
Lidocaine spray, which temporarily reduces penile sensitivity, is another common PE treatment. Pairing it with tadalafil appears to produce results neither achieves alone. A randomized controlled trial in men with both ED and PE found that tadalafil plus lidocaine spray increased ejaculatory latency from about 26 seconds to nearly 199 seconds, while tadalafil alone showed no significant change. Sexual satisfaction scores followed the same pattern.16PubMed Central. Evaluation of the Efficacy and Safety of On-Demand Tadalafil Alone or Combined With Lidocaine Spray for Treating Patients With Comorbid Erectile Dysfunction and Premature Ejaculation A separate study in men with lifelong PE confirmed the synergy, concluding that daily tadalafil has a role in PE treatment that becomes significant when combined with the desensitizing effect of lidocaine.17PubMed. A randomized single-center study to compare the efficacy and tolerability of tadalafil once daily plus lidocaine anesthetic spray on premature ejaculation A large network meta-analysis pooling 44 trials listed topical lidocaine with tadalafil among the treatment regimens associated with a significant increase in ejaculatory latency.18International Journal of Impotence Research. Pharmacological interventions for premature ejaculation: a mixed-treatment comparison network meta-analysis of randomized clinical trials
The logic here mirrors the SSRI combination: tadalafil addresses erection confidence and potentially the peripheral smooth-muscle pathway, while lidocaine reduces local sensitivity. Together they tackle two different contributors to early ejaculation. This multi-target approach reflects a growing trend in PE management, where clinicians layer treatments rather than relying on a single drug.
Patient-Reported Satisfaction May Tell a Different Story Than the Stopwatch
One underappreciated wrinkle in the PE research is the gap between what a stopwatch measures and how a man (and his partner) experience sex. Ejaculatory latency measured in seconds is the standard research endpoint, but it is a crude stand-in for what most people actually care about: perceived control, satisfaction, and distress. A randomized, placebo-controlled trial measuring patient-reported outcomes with a validated questionnaire found that men taking daily tadalafil scored significantly higher on ejaculatory control, satisfaction, and distress measures than the placebo group after six weeks of treatment.19Andrologia. Efficacy and safety of daily use of tadalafil in treatment of patients with premature ejaculation: A randomised placebo-controlled clinical trial
How can a drug improve subjective experience without dramatically changing the clock? Part of the answer is erection quality. When a man feels confident that his erection will last, the psychological pressure to rush dissipates. He may feel more in control even if the measured time to ejaculation shifts by only a few seconds. Reduced performance anxiety alone can transform the sexual experience. This is one reason some clinicians prescribe tadalafil for PE even when the stopwatch data is unimpressive: if the patient feels genuinely better, the clinical goal has been met.
Do Benefits Last After Stopping the Drug
One promising finding is that the benefits of tadalafil may persist after you stop taking it, at least in certain cases. The study of men with co-existing ED and PE found that improvements in both ejaculatory latency and erectile function scores remained statistically significant two years after treatment stopped.4PubMed Central. Short- and long-term follow-up results of daily 5-mg tadalafil as a treatment for erectile dysfunction and premature ejaculation The researchers suggested that a period of improved sexual function may “reset” the psychological and vascular patterns that contributed to the problem. This is a single study, not a robust evidence base, but it hints that tadalafil might do more than provide a temporary chemical crutch in the right patient population. Other PE treatments, particularly SSRIs, often see a return of symptoms once the drug is withdrawn, so any treatment with lasting effects is of real clinical interest.
Lifelong PE Versus Acquired PE
The distinction between lifelong and acquired premature ejaculation matters enormously when evaluating tadalafil. Lifelong PE, present from the very first sexual experiences, is thought to be rooted in central serotonin signaling and may have a strong genetic component. Acquired PE develops later in life and often accompanies other conditions such as ED, anxiety, prostatitis, or thyroid disorders. The placebo-controlled trial that found tadalafil ineffective was conducted specifically in men with lifelong PE, and the authors were explicit about the drug failing to beat placebo in that group.2PubMed Central. Effect of a tadalafil 5-mg single daily dose on lifelong premature ejaculation: A single-blinded placebo-controlled study Meanwhile, the studies showing clear benefit largely drew from populations with acquired PE or co-existing ED.4PubMed Central. Short- and long-term follow-up results of daily 5-mg tadalafil as a treatment for erectile dysfunction and premature ejaculation
If your PE started recently, and especially if you have also noticed changes in your erections, tadalafil is a reasonable option to discuss with a urologist. If you have had PE your entire sexual life with no erection problems, the evidence suggests you would be better served by an SSRI or dapoxetine, with tadalafil potentially added as a second agent if the first-line drug is not enough on its own.
Off-Label Prescribing and What Guidelines Say
Tadalafil remains off-label for premature ejaculation everywhere. Dapoxetine is the only drug specifically approved for PE (in Europe and various other markets, though not the United States). Standard treatment guidelines list daily or on-demand SSRIs, topical anesthetics, and behavioral therapy as the primary options. PDE5 inhibitors occupy a secondary position, usually recommended when PE coexists with ED or when first-line treatments have failed.
That said, clinical practice often runs ahead of formal approvals. The BSSM’s position statement explicitly supports the early use of PDE5 inhibitors either alone or alongside dapoxetine or psychosexual interventions, reflecting a growing clinical comfort with these combinations.6PubMed Central. British Society for Sexual Medicine (BSSM) Position Statement on Premature Ejaculation In practical terms, many urologists and sexual-medicine specialists already prescribe tadalafil for PE, particularly the daily low-dose formulation, when the clinical picture includes erection concerns or when patients want to avoid SSRIs and their associated side effects like reduced libido and emotional blunting.
The safety profile of daily tadalafil is well characterized from its long use for ED and benign prostatic hyperplasia. Headache, indigestion, back pain, and nasal congestion are the most common complaints, and they tend to be mild. The more relevant safety consideration for PE patients is drug interactions: combining tadalafil with dapoxetine or an SSRI requires attention to potential additive effects on blood pressure and serotonin levels, which is why these combinations should be managed by a physician rather than improvised at home.
When Tadalafil Alone Makes Sense and When It Does Not
Putting the evidence together, a few practical patterns emerge. Tadalafil alone is most likely to help if you have acquired PE alongside erectile difficulties. In that scenario, restoring reliable erection function often resolves the ejaculatory problem as a downstream effect. It is least likely to help if you have lifelong PE with normal erections, where the issue is almost certainly upstream in serotonin signaling and a stopwatch-measured improvement over placebo has not been demonstrated. In between those poles, if you have borderline erections you have not recognized as a problem, or if performance anxiety is a major driver, tadalafil may offer subjective improvements in control and confidence that matter even if the measured time gain is small.
For anyone considering tadalafil specifically for PE, a combination approach has the strongest evidence. Pairing it with an SSRI, dapoxetine, or even a topical numbing spray consistently outperforms either treatment used in isolation. The fact that tadalafil matched dapoxetine head-to-head in at least one trial suggests it brings real pharmacological value to the table, not just a placebo boost.13PubMed Central. Prospective comparison of tadalafil 5 mg, dapoxetine 30 mg, and the combination of both in the treatment of premature ejaculation But that value is magnified when another mechanism is working alongside it. Think of tadalafil as a useful partner rather than a solo solution for PE.